Please assess the completion status of the following clinical trial:

Trial Title: Mast Cells in Acid-induced Intestinal Permeability

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* healthy~Exclusion Criteria:~* - refused informed consent~* pregnant women or women who are breastfeeding~* symptoms or history of gastrointestinal disease~* diabetes mellitus~* coagulation disorders/anticoagulant therapy~* first degree relatives with celiac disease, Crohn's disease or type I diabetes mellitus~* taking antihistamines, ketotifen, cromoglycate, acetylsalicylates, NSAIDs, anticholinergics, theophylline, β2-agonists, codeine or opioid derivatives 2 weeks prior to the study~* taking steroid or immunosuppressive drugs 6 months prior to the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- placebo (Type: PLACEBO_COMPARATOR): mannitol
- disodium cromoglycate (Type: ACTIVE_COMPARATOR): disodium cromoglycate

Based on this trial design, predict the completion outcome and termination type (if applicable).